Taking health equity seriously during the pandemic requires some minimal degree of vaccine price control. Countries should make vaccine contract details public, specify a fair price, and outline how they plan to meet it, argues Felix Stein
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
